Ni YB - Search Results

1

Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.

Tsang JY, Huang YH, Luo MH, Ni YB, Chan SK, Lui PC, Yu AM, Tan PH, Tse GM. Tsang JY, et al. Among authors: ni yb. Breast Cancer Res Treat. 2012 Nov;136(2):407-17. doi: 10.1007/s10549-012-2271-6. Epub 2012 Sep 30. Breast Cancer Res Treat. 2012. PMID: 23053657

2

Relationship between columnar cell changes and low-grade carcinoma in situ of the breast--a cytogenetic study.

Go EM, Tsang JY, Ni YB, Yu AM, Mendoza P, Chan SK, Lam CC, Lui PC, Tan PH, Tse GM. Go EM, et al. Among authors: ni yb. Hum Pathol. 2012 Nov;43(11):1924-31. doi: 10.1016/j.humpath.2012.02.001. Epub 2012 Apr 27. Hum Pathol. 2012. PMID: 22542249

3

Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.

Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, Tse GM. Luo MH, et al. Among authors: ni yb. Hum Pathol. 2013 Jul;44(7):1241-50. doi: 10.1016/j.humpath.2012.10.009. Epub 2013 Jan 17. Hum Pathol. 2013. PMID: 23332923

4

Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.

Mujtaba SS, Ni YB, Tsang JY, Chan SK, Yamaguchi R, Tanaka M, Tan PH, Tse GM. Mujtaba SS, et al. Among authors: ni yb. Ann Surg Oncol. 2013 Sep;20(9):2842-9. doi: 10.1245/s10434-013-2955-0. Epub 2013 Mar 29. Ann Surg Oncol. 2013. PMID: 23539156 Clinical Trial.

5

Increased lymphocytic infiltration in breast cancer correlated with molecular subtypes and HER2 gene amplification.

Tsang JY, Ni YB, Chan SK, Yamaguchi R, Tanaka M, Tan PH, Tse GM. Tsang JY, et al. Among authors: ni yb. Histopathology. 2013 May;62(6):963-5. doi: 10.1111/his.12085. Epub 2013 Mar 28. Histopathology. 2013. PMID: 23551496 No abstract available.

6

CX3CL1 expression is associated with poor outcome in breast cancer patients.

Tsang JY, Ni YB, Chan SK, Shao MM, Kwok YK, Chan KW, Tan PH, Tse GM. Tsang JY, et al. Among authors: ni yb. Breast Cancer Res Treat. 2013 Aug;140(3):495-504. doi: 10.1007/s10549-013-2653-4. Epub 2013 Aug 4. Breast Cancer Res Treat. 2013. PMID: 23912959

7

Columnar cell-like changes in the male breast.

Ni YB, Mujtaba S, Shao MM, Lacambra M, Tsang JY, Chan SK, Tse GM. Ni YB, et al. J Clin Pathol. 2014 Jan;67(1):45-8. doi: 10.1136/jclinpath-2013-201631. Epub 2013 Aug 6. J Clin Pathol. 2014. PMID: 23922357

8

TTF-1 expression in breast carcinoma: an unusual but real phenomenon.

Ni YB, Tsang JY, Shao MM, Chan SK, Tong J, To KF, Tse GM. Ni YB, et al. Histopathology. 2014 Mar;64(4):504-11. doi: 10.1111/his.12287. Epub 2013 Nov 25. Histopathology. 2014. PMID: 24111789

9

P-cadherin and vimentin are useful basal markers in breast cancers.

Tsang JY, Au SK, Ni YB, Shao MM, Siu WM, Hui SW, Chan SK, Chan KW, Kwok YK, Chan KF, Tse GM. Tsang JY, et al. Among authors: ni yb. Hum Pathol. 2013 Dec;44(12):2782-91. doi: 10.1016/j.humpath.2013.07.029. Epub 2013 Oct 16. Hum Pathol. 2013. PMID: 24139214

10

Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.

Tsang JY, Kwok YK, Chan KW, Ni YB, Chow WN, Lau KF, Shao MM, Chan SK, Tan PH, Tse GM. Tsang JY, et al. Among authors: ni yb. Breast Cancer Res Treat. 2013 Nov;142(2):311-22. doi: 10.1007/s10549-013-2756-y. Epub 2013 Nov 2. Breast Cancer Res Treat. 2013. PMID: 24186057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page